中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

血清异常凝血酶原在肝细胞癌诊疗中的意义

孙玉 张洪海 袁春旺 扈彩霞 刘博君 崔石昌 钱智玲 张英华 张永宏 郑加生

引用本文:
Citation:

血清异常凝血酶原在肝细胞癌诊疗中的意义

DOI: 10.3969/j.issn.1001-5256.2018.10.017
基金项目: 

国家自然科学基金资助项目(81472328); 

详细信息
  • 中图分类号: R735.7

Value of serum des-γ-carboxy-prothrombin in the diagnosis and treatment of hepatocellular carcinoma

Research funding: 

 

  • 摘要: 目的研究血清异常凝血酶原(DCP)在肝细胞癌(HCC)患者中的表达水平及其与肿瘤性状、病理及临床特征之间的关系。方法选择2016年1月-2018年3月在首都医科大学附属北京佑安医院住院治疗并经外科手术切除组织病理确诊的肝细胞癌患者80例,检测患者术前血清DCP及AFP水平并进行相关性分析,分析患者的临床信息、影像学、病理学结果与DCP水平的关系。计量资料两组间比较采用Mann-Whitney U检验,多组间比较采用Kruskal-Wallis H检验,进一步两两比较采用Mann-Whitney U检验,两组样本的相关性检验采用Spearman相关分析。结果 HCC患者血清AFP与DCP水平无明显相关性(r=0. 141,P>0. 05); HCC患者血清DCP水平与肿瘤直径之间显著相关(r=0. 563,P <0. 01);肝内多发肿瘤、合并远处转移、存在肉眼或微观血管侵犯的HCC患者血清DCP水平分别高于肝内单发肿瘤(Z=-5. 484,P <0. 001)、无远处转移(Z=-4. 569,P <0. 001)、无肉眼血管侵犯(Z=-3. 713,P <...

     

  • [1]PETRUZZIELLO A.Epidemiology of hepatitis B virus (HBV) and hepatitis C virus (HCV) related hepatocellular carcinoma[J].Open Virol J, 2018, 12:26-32.
    [2]EMOKPAE MA, ADEJUMOL BG, ABDU A, et al.Serum alphafetoprotein level is higher in hepatitis C than hepatitis B infected chronic liver disease patients[J].Niger Med J, 2013, 54 (6) :426-429.
    [3]National Health and Family Planning Commission of the People's Republic of China.Diagnosis, management, and treatment of hepatocellular carcinoma (V 2017) [J].J Clin Hepatol, 2017, 33 (8) :1419-1431. (in Chinese) 中华人民共和国国家卫生和计划生育委员会.原发性肝癌诊疗规范 (2017年版) [J].临床肝胆病杂志, 2017, 33 (8) :1419-1431.
    [4] LIEBMAN HA, FURIE BC, TONG MJ, et al.Des-gammacarboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma[J].N Engl J Med, 1984, 310 (22) :1427-1431.
    [5]BAEK YH, LEE JH, JANG JS, et al.Diagnostic role and correlation with staging systems of PIVKA-II compared with AFP[J].Hepatogastroenterology, 2009, 56 (91-92) :763-767.
    [6]GIANNELLI G, ANTONACI S.New frontiers in biomarkers for hepatocellular carcinoma[J].Dig Liver Dis, 2006, 38 (11) :854-859.
    [7]SHIMADA M, YONEMURA Y, IJICHI H, et al.Living donor liver transplantation for hepatocellular carcinoma:A special reference to a preoperative des-gamma-carboxy prothrombin value[J].Transplant Proc, 2005, 37 (2) :1177-1179.
    [8]MIYAAKI H, NAKASHIMA O, KUROGI M, et al.Lens culinaris agglutinin-reactive alpha-fetoprotein and protein induced by vitamin K absence II are potential indicators of a poor prognosis:A histopathological study of surgically resected hepatocellular carcinoma[J].J Gastroenterol, 2007, 42 (12) :962-968.
    [9]GOTOH M, NAKATANI T, MASUDA T, et al.Prediction of invasive activities in hepatocellular carcinomas with special reference to alphafetoprotein and des-gamma-carboxyprothrombin[J].Jpn J Clin Oncol, 2003, 33 (10) :522-526.
    [10]HAGIWARA S, KUDO M, KAWASAKI T, et al.Prognostic factors for portal venous invasion in patients with hepatocellular carcinoma[J].JGastroenterol, 2006, 41 (12) :1214-1219.
    [11]ZAKHARY NI, KHODEER SM, SHAFIK HE, et al.Impact of PIVKA-II in diagnosis of hepatocellular carcinoma[J].J Adv Res, 2013, 4 (6) :539-546.
    [12]DURAZO FA, BLATT LM, COREY WG, et al.Des-gammacarboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma[J].JGastroenterol Hepatol, 2008, 23 (10) :1541-1548.
    [13]BAE HM, LEE JH, YOON JH, et al.Protein induced by vitamin Kabsence or antagonist-II production is a strong predictive marker for extrahepatic metastases in early hepatocellular carcinoma:a prospective evaluation[J].BMC Cancer, 2011, 11:435.
    [14]CARR BI, KANKE F, WISE M, et al.Clinical evaluation of lens culinaris agglutinin-reactive alpha-fetoprotein and des-gammacarboxy prothrombin in histologically proven hepatocellular carcinoma in the United States[J].Dig Dis Sci, 2007, 52 (3) :776-782.
    [15]PARK MS, LEE KW, KIM H, et al.Usefulness of PIVKA-II after living-donor liver transplantation for hepatocellular carcinoma[J].Transplant Proc, 2017, 49 (5) :1109-1113.
    [16]UEDA N, SHIRAHA H, FUJIKAWA T, et al.Exon 2 deletion splice variant of gamma-glutamyl carboxylase causes des-gamma-carboxy prothrombin production in hepatocellular carcinoma cell lines[J].Mol Oncol, 2008, 2 (3) :241-249.
    [17]FUJIKAWA T1, SHIRAHA H, UEDA N, et al.Des-gammacarboxyl prothrombin-promoted vascular endothelial cell proliferation and migration[J].J Biol Chem, 2007, 282 (12) :8741-8742.
    [18] QIN X, TANG G, GAO R, et al.A multicenter study on PIVKAreference interval of healthy population and establishment of PIVKAcutoff value for hepatocellular carcinoma diagnosis in China[J].Int J Lab Hematol, 2017, 39 (4) :392-401.
  • 加载中
计量
  • 文章访问数:  2646
  • HTML全文浏览量:  45
  • PDF下载量:  408
  • 被引次数: 0
出版历程
  • 出版日期:  2018-10-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回